Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Immunoprecipitation Market by Type (Individual IP, Coimmunoprecipitation, CHIP), By Application (Academics, Research Institutes, Pharmaceutical and Biotechnology Companies) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Immunoprecipitation Market by Type (Individual IP, Coimmunoprecipitation, CHIP), By Application (Academics, Research Institutes, Pharmaceutical and Biotechnology Companies) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 130055 3300 Medical Devices & Consumables 377 241 Pages 5 (36)
                                          

The global immunoprecipitation market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The individual IP segment is expected to account for the largest share of the global immunoprecipitation market in terms of revenue, followed by coimmunoprecipitation and CHIP segments. The individual IP segment is projected to grow at a CAGR of 6.2% during the forecast period, from 2021 to 2030. North America accounted for the largest share in terms of revenue in 2018 and is expected to continue its dominance throughout the forecast period, owing primarily due to high adoption rates among research institutes and pharmaceutical companies in this region. Europe accounted for second-largest share in terms of revenue and Asia Pacific was third-largest contributor with respect to revenue generation during 2018.

  1. The market for immunoprecipitation is expected to reach $3,890 million by 2022.
  2. Immunoprecipitation is used in the diagnosis and treatment of various diseases such as cancer, HIV/AIDS, and hepatitis.
  3. Immunoprecipitation can be used in the detection of infectious agents such as bacteria and viruses.
  4. Immunoprecipitation can be used in the detection of genetic mutations.

Industry Growth Insights published a new data on “Immunoprecipitation Market”. The research report is titled “Immunoprecipitation Market research by Types (Individual IP, Coimmunoprecipitation, CHIP), By Applications (Academics, Research Institutes, Pharmaceutical and Biotechnology Companies), By Players/Companies Thermo Fisher Scientific, Abcam, Merck KGaA, Agarose Bead Technologies, ...”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Immunoprecipitation Market Research Report

By Type

Individual IP, Coimmunoprecipitation, CHIP

By Application

Academics, Research Institutes, Pharmaceutical and Biotechnology Companies

By Companies

Thermo Fisher Scientific, Abcam, Merck KGaA, Agarose Bead Technologies, ...

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

241

Number of Tables & Figures

169

Customization Available

Yes, the report can be customized as per your need.


Global Immunoprecipitation Industry Outlook


Global Immunoprecipitation Market Report Segments:

The global Immunoprecipitation market is segmented on the basis of:

Types

Individual IP, Coimmunoprecipitation, CHIP

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Academics, Research Institutes, Pharmaceutical and Biotechnology Companies

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Thermo Fisher Scientific
  2. Abcam
  3. Merck KGaA
  4. Agarose Bead Technologies
  5. ...

Global Immunoprecipitation Market Overview


Highlights of The Immunoprecipitation Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Individual IP
    2. Coimmunoprecipitation
    3. CHIP
  1. By Application:

    1. Academics
    2. Research Institutes
    3. Pharmaceutical and Biotechnology Companies
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Immunoprecipitation Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Immunoprecipitation Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Immunoprecipitation is a technique used to isolate proteins from a sample. Proteins can be isolated by affinity chromatography using an antibody against the protein of interest.

Some of the key players operating in the immunoprecipitation market are Thermo Fisher Scientific, Abcam, Merck KGaA, Agarose Bead Technologies.

The immunoprecipitation market is expected to register a CAGR of 5.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Immunoprecipitation Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Immunoprecipitation Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Immunoprecipitation Market - Supply Chain
   4.5. Global Immunoprecipitation Market Forecast
      4.5.1. Immunoprecipitation Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Immunoprecipitation Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Immunoprecipitation Market Absolute $ Opportunity

5. Global Immunoprecipitation Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Immunoprecipitation Market Size and Volume Forecast by Type
      5.3.1. Individual IP
      5.3.2. Coimmunoprecipitation
      5.3.3. CHIP
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Immunoprecipitation Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Immunoprecipitation Market Size and Volume Forecast by Application
      6.3.1. Academics
      6.3.2. Research Institutes
      6.3.3. Pharmaceutical and Biotechnology Companies
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Immunoprecipitation Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Immunoprecipitation Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Immunoprecipitation Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Immunoprecipitation Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Immunoprecipitation Demand Share Forecast, 2019-2029

9. North America Immunoprecipitation Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Immunoprecipitation Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Immunoprecipitation Market Size and Volume Forecast by Application
      9.4.1. Academics
      9.4.2. Research Institutes
      9.4.3. Pharmaceutical and Biotechnology Companies
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Immunoprecipitation Market Size and Volume Forecast by Type
      9.7.1. Individual IP
      9.7.2. Coimmunoprecipitation
      9.7.3. CHIP
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Immunoprecipitation Demand Share Forecast, 2019-2029

10. Latin America Immunoprecipitation Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Immunoprecipitation Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Immunoprecipitation Market Size and Volume Forecast by Application
      10.4.1. Academics
      10.4.2. Research Institutes
      10.4.3. Pharmaceutical and Biotechnology Companies
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Immunoprecipitation Market Size and Volume Forecast by Type
      10.7.1. Individual IP
      10.7.2. Coimmunoprecipitation
      10.7.3. CHIP
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Immunoprecipitation Demand Share Forecast, 2019-2029

11. Europe Immunoprecipitation Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Immunoprecipitation Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Immunoprecipitation Market Size and Volume Forecast by Application
      11.4.1. Academics
      11.4.2. Research Institutes
      11.4.3. Pharmaceutical and Biotechnology Companies
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Immunoprecipitation Market Size and Volume Forecast by Type
      11.7.1. Individual IP
      11.7.2. Coimmunoprecipitation
      11.7.3. CHIP
   11.8. Basis Point Share (BPS) Analysis by Tpe
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Immunoprecipitation Demand Share, 2019-2029

12. Asia Pacific Immunoprecipitation Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Immunoprecipitation Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Immunoprecipitation Market Size and Volume Forecast by Application
      12.4.1. Academics
      12.4.2. Research Institutes
      12.4.3. Pharmaceutical and Biotechnology Companies
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Immunoprecipitation Market Size and Volume Forecast by Type
      12.7.1. Individual IP
      12.7.2. Coimmunoprecipitation
      12.7.3. CHIP
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Immunoprecipitation Demand Share, 2019-2029

13. Middle East & Africa Immunoprecipitation Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Immunoprecipitation Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Immunoprecipitation Market Size and Volume Forecast by Application
      13.4.1. Academics
      13.4.2. Research Institutes
      13.4.3. Pharmaceutical and Biotechnology Companies
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Immunoprecipitation Market Size and Volume Forecast by Type
      13.7.1. Individual IP
      13.7.2. Coimmunoprecipitation
      13.7.3. CHIP
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Immunoprecipitation Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Immunoprecipitation Market: Market Share Analysis
   14.2. Immunoprecipitation Distributors and Customers
   14.3. Immunoprecipitation Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Thermo Fisher Scientific
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Abcam
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Merck KGaA
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Agarose Bead Technologies
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. ...
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. COMPANY6
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. COMPANY7
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. COMPANY8
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. COMPANY9
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. COMPANY 10
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us